company background image
CMP logo

Compumedics CHIA:CMP Stock Report

Last Price

AU$0.30

Market Cap

AU$52.4m

7D

5.2%

1Y

60.5%

Updated

24 Nov, 2024

Data

Company Financials

Compumedics Limited

CHIA:CMP Stock Report

Market Cap: AU$52.4m

CMP Stock Overview

Engages in the research, development, manufacture, and distribution of medical equipment and related technologies in Australia, the Asia Pacific, the United States, and Europe. More details

CMP fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Risk Analysis

Earnings have declined by 20.6% per year over past 5 years

Shareholders have been diluted in the past year

Does not have a meaningful market cap (A$52M)


Compumedics Limited Competitors

SomnoMed

ASX:SOM

AU$55.1m

Clever Culture Systems

ASX:LBT

AU$33.4m

Universal Biosensors

ASX:UBI

AU$35.8m

Nova Eye Medical

ASX:EYE

AU$34.4m

Price History & Performance

Summary of all time highs, changes and price drops for Compumedics
Historical stock prices
Current Share PriceAU$0.30
52 Week HighAU$0.44
52 Week LowAU$0.23
Beta1.13
11 Month Change0%
3 Month Change-4.69%
1 Year Change60.53%
33 Year Change-10.29%
5 Year Change-62.11%
Change since IPO177.27%

Recent News & Updates

Recent updates

Shareholder Returns

CMPAU Medical EquipmentAU Market
7D5.2%0.5%0.9%
1Y60.5%14.8%18.4%

Return vs Industry: CMP exceeded the Australian Medical Equipment industry which returned 14.8% over the past year.

Return vs Market: CMP exceeded the Australian Market which returned 18.4% over the past year.

Price Volatility

Is CMP's price volatile compared to industry and market?
CMP volatility
CMP Average Weekly Movement8.4%
Medical Equipment Industry Average Movement9.4%
Market Average Movement8.5%
10% most volatile stocks in AU Market17.5%
10% least volatile stocks in AU Market3.2%

Stable Share Price: CMP has not had significant price volatility in the past 3 months compared to the Australian market.

Volatility Over Time: CMP's weekly volatility has decreased from 15% to 8% over the past year.

About the Company

FoundedEmployeesCEOWebsite
1987155David Burtonwww.compumedics.com.au

Compumedics Limited engages in the research, development, manufacture, and distribution of medical equipment and related technologies in Australia, the Asia Pacific, the United States, and Europe. It provides sleep diagnostics products, including Somfit/Somfit Pro, a wearable device for collecting patients’ physiological data; Somté PSG; Okti; Grael PSG; Grael 4K PSG; Falcon PSG; Falcon HST; Somté, an investigative tool; Siesta 802; and Somté PSG. The company also offers neurology diagnostics, such as ONsight A.V.S. for monitoring patient's home ambulatory studies; Grael 4K PSG:EEG amplifiers; Grael 4K-EEG amplifiers; Grael LT EEG System amplifiers; Neuvo 64-512 Channel LTM EEG monitoring systems; Okti, an portable EEG amplifier; and Siesta 802, a multi-functional ambulatory recording device.

Compumedics Limited Fundamentals Summary

How do Compumedics's earnings and revenue compare to its market cap?
CMP fundamental statistics
Market capAU$52.37m
Earnings (TTM)-AU$338.00k
Revenue (TTM)AU$50.26m

1.0x

P/S Ratio

-155.0x

P/E Ratio

Is CMP overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CMP income statement (TTM)
RevenueAU$50.26m
Cost of RevenueAU$23.65m
Gross ProfitAU$26.61m
Other ExpensesAU$26.95m
Earnings-AU$338.00k

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.0018
Gross Margin52.94%
Net Profit Margin-0.67%
Debt/Equity Ratio38.3%

How did CMP perform over the long term?

See historical performance and comparison